Home Tools
Log in
Cart

Disease Focused

These include focused libraries of small-molecule compounds with potential biological activity towards certain diseases (such as Anti-Cancer Compound Library, Anti-Diabetic Compound Library, Anti-Cardiovascular Disease Compound Library, etc.).

Cat No. product name
L1719 Nsp15-Targeted Compound Library (CADD) 470个具有潜在抗COVID-19活性的化合物集合,适用于高通量和高内涵筛选,是开发抗COVID-19药物的有力工具; 470 compounds
L2190 Anti-Lung Cancer Compound Library 1566种与肺癌相关的化合物,可以用于抗肺癌药物研发和药理研究; 1566 compounds
L7110 Anti-Hypertension Compound Library 719种高血压相关的小分子,用于高通量和高内涵筛选; 719 compounds
L4510 Anti-Parasitic Compound Library 525种具有抗寄生虫活性,且结构新颖的小分子化合物; 525 compounds
L2180 Anti-Cancer Library Plus 1468种抗肿瘤相关、结构新颖的化合物; 1468 compounds
L1718 X Domain-Targeted Compound Library (CADD) 463个具有潜在抗COVID-19活性的化合物集合,适用于高通量和高内涵筛选,是开发抗COVID-19药物的有力工具; 463 compounds
L1714 RBD-Targeted Compound Library (CADD) 206个具有潜在抗COVID-19活性的化合物集合,适用于高通量和高内涵筛选,是开发抗COVID-19药物的有力工具; 206 compounds
L1711 Anti-COVID-19 Compound Library (CADD) 362个具有潜在抗COVID-19活性的化合物集合,适用于高通量和高内涵筛选,是开发抗COVID-19药物的有力工具; 362 compounds
L5400 Anti-Cardiovascular Disease Compound Library 1428种心血管疾病相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; 1428 compounds
L2130 Anti-Cancer Metabolism Compound Library 1280种癌细胞代谢相关的生物活性小分子化合物的特有集合,用于肿瘤相关的研究以及抗肿瘤药物的筛选,用于高通量、高内涵筛选; 1280 compounds
L1713 ACE2-Targeted Compound Library (CADD) 462个具有潜在抗COVID-19活性的化合物集合,适用于高通量和高内涵筛选,是开发抗COVID-19药物的有力工具; 462 compounds
L2140 Cancer Cell Differentiation Compound Library 413个诱导肿瘤细胞分化化合物的独特集合,可用于高通量筛选和高内涵筛选; 413 compounds
L4700 Immunology/Inflammation Compound Library 3483种具有抗炎症活性的化合物的特有集合,可用于高通量筛选和高内涵筛选; 3483 compounds
L2170 Immuno-Oncology Compound Library 454种靶向肿瘤免疫治疗靶点的小分子,可用于高通量和高内涵筛选,是研究肿瘤免疫治疗的有力工具; 454 compounds
L2192 Anti-Pancreatic Cancer Compound Library 1697种与胰腺癌相关的化合物,可以用于高通量和高内涵筛选; 1697 compounds
L9830 Anti-Parkinson's Disease Compound Library 908种帕金森病相关的化合物集合,可用于高通量和高内涵筛选; 908 compounds
L8400 Hematonosis Compound Library 524种造血系统疾病相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; 524 compounds
L7100 Anti-Obesity Compound Library 1359个抗肥胖化合物的独特集合,可用于高通量筛选和高内涵筛选; 1359 compounds
L2152 Targeted Therapy Drug Library 121个肿瘤靶向治疗药物,可以用于高通量和高内涵筛选; 121 compounds
L1710 Anti-COVID-19 Compound Library 2446种对SARS-CoV-2有抑制作用或潜在抑制作用的化合物集合,可用于高通量和高内涵筛选; 2446 compounds
L2160 Anti-Cancer Active Compound Library 2114种具有抗肿瘤活性的化合物的特有集合,用于高通量、高内涵筛选; 2114 compounds
L2110 Anti-Cancer Approved Drug Library 1726个具有抗癌活性小分子的独特集合,所有化合物都经过了严格的临床前研究和临床试验,由FDA、EMA或NMPA批准上市,可用于高通量、高内涵筛选。 1726 compounds
L9840 Anti-Alzheimer's Disease Compound Library 1040 种阿尔茨海默症相关的化合物集合,可用于高通量和高内涵筛选; 1040 compounds
L5200 Anti-Metabolism Disease Compound Library 1558个代谢疾病相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; 1558 compounds
L4660 Anti-Nervous System Disease Library 1246种神经系统相关、结构新颖的化合物; 1246 compounds
L4500 Anti-Fungal Compound Library 253个抗真菌活性化合物的独特集合,包含作用于真菌相关靶点的化合物和临床中用于真菌类疾病的药物,是相关疾病药物筛选的有效工具。 253 compounds
L4710 Nonsteroidal Anti-Inflammatory Compound Library 530种非甾体类的抗炎相关化合物,可用于高通量和高内涵筛选; 530 compounds
L1716 PLpro-Targeted Compound Library (CADD) 474个具有潜在抗COVID-19活性的化合物集合,适用于高通量和高内涵筛选,是开发抗COVID-19药物的有力工具; 474 compounds
L1715 Nsp16-Targeted Compound Library (CADD) 281个具有潜在抗COVID-19活性的化合物集合,适用于高通量和高内涵筛选,是开发抗COVID-19药物的有力工具; 281 compounds
L2191 Anti-Breast Cancer Compound Library 1436种与乳腺癌相关的化合物,可以用于抗乳腺癌药物研发和药理研究; 1436 compounds
L4520 Anti-Bacterial Compound Library 1429种具有抗菌活性的化合物,是抗菌药物研发的有力工具; 1429 compounds
L9810 Anti-Fibrosis Compound Library 1180种潜在的抗纤维化分子,是研究纤维化的有效工具,可以用于高通量筛选和高内涵筛选; 1180 compounds
L2120 Anti-Cancer Clinical Compound Library 1990个具有抗癌活性小分子的独特集合,可用于高通量高内涵筛选。 1990 compounds
L2150 Anti-Cancer Drug Library 2478个具有抗癌活性小分子的独特集合,生物活性已经临床前实验证实,可用于高通量、高内涵筛选; 2478 compounds
L1700 Anti-Virus Compound Library 800种具有抗病毒活性的化合物的特有集合,是筛选新型抗病毒药的有效工具;可用于高通量筛选和高内涵筛选; 800 compounds
L1717 RdRP-Targeted Compound Library (CADD) 464个具有潜在抗COVID-19活性的化合物集合,适用于高通量和高内涵筛选,是开发抗COVID-19药物的有力工具; 464 compounds
L1900 Anti-Diabetic Compound Library 690种生物活性小分子化合物; 690 compounds
L2151 Chemotherapy Drug Library 51个肿瘤化疗药物,可以用于高通量和高内涵筛选; 51 compounds
L1800 Anti-Infection Compound Library 2977种具有抗感染活性的化合物的特有集合,包括抗细菌、抗真菌、抗巨细胞病毒、抗HIV、抗SARS、抗流感等活性; 2977 compounds
L1712 3CLpro-Targeted Compound Library (CADD) 161个具有潜在抗COVID-19活性的化合物集合,适用于高通量和高内涵筛选,是开发抗COVID-19药物的有力工具; 161 compounds
L2620 Anti-Neurodegenerative Disease Compound Library 1622种与神经退行性疾病相关的化合物,可用于高通量和高内涵筛选; 1622 compounds
L2100 Anti-Cancer Compound Library 100种肿瘤相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; 100 compounds
Nsp15-Targeted Compound Library (CADD)
L1719 compounds - 470
Anti-Lung Cancer Compound Library
L2190 compounds - 1566
Anti-Hypertension Compound Library
L7110 compounds - 719
Anti-Parasitic Compound Library
L4510 compounds - 525
Anti-Cancer Library Plus
L2180 compounds - 1468
X Domain-Targeted Compound Library (CADD)
L1718 compounds - 463
RBD-Targeted Compound Library (CADD)
L1714 compounds - 206
Anti-COVID-19 Compound Library (CADD)
L1711 compounds - 362
Anti-Cardiovascular Disease Compound Library
L5400 compounds - 1428
Anti-Cancer Metabolism Compound Library
L2130 compounds - 1280
ACE2-Targeted Compound Library (CADD)
L1713 compounds - 462
Cancer Cell Differentiation Compound Library
L2140 compounds - 413
Immunology/Inflammation Compound Library
L4700 compounds - 3483
Immuno-Oncology Compound Library
L2170 compounds - 454
Anti-Pancreatic Cancer Compound Library
L2192 compounds - 1697
Anti-Parkinson's Disease Compound Library
L9830 compounds - 908
Hematonosis Compound Library
L8400 compounds - 524
Anti-Obesity Compound Library
L7100 compounds - 1359
Targeted Therapy Drug Library
L2152 compounds - 121
Anti-COVID-19 Compound Library
L1710 compounds - 2446
Anti-Cancer Active Compound Library
L2160 compounds - 2114
Anti-Cancer Approved Drug Library
L2110 compounds - 1726
Anti-Alzheimer's Disease Compound Library
L9840 compounds - 1040
Anti-Metabolism Disease Compound Library
L5200 compounds - 1558
Anti-Nervous System Disease Library
L4660 compounds - 1246
Anti-Fungal Compound Library
L4500 compounds - 253
Nonsteroidal Anti-Inflammatory Compound Library
L4710 compounds - 530
PLpro-Targeted Compound Library (CADD)
L1716 compounds - 474
Nsp16-Targeted Compound Library (CADD)
L1715 compounds - 281
Anti-Breast Cancer Compound Library
L2191 compounds - 1436
Anti-Bacterial Compound Library
L4520 compounds - 1429
Anti-Fibrosis Compound Library
L9810 compounds - 1180
Anti-Cancer Clinical Compound Library
L2120 compounds - 1990
Anti-Cancer Drug Library
L2150 compounds - 2478
Anti-Virus Compound Library
L1700 compounds - 800
RdRP-Targeted Compound Library (CADD)
L1717 compounds - 464
Anti-Diabetic Compound Library
L1900 compounds - 690
Chemotherapy Drug Library
L2151 compounds - 51
Anti-Infection Compound Library
L1800 compounds - 2977
3CLpro-Targeted Compound Library (CADD)
L1712 compounds - 161
Anti-Neurodegenerative Disease Compound Library
L2620 compounds - 1622
Anti-Cancer Compound Library
L2100 compounds - 100